Listed

biote Corp.

BTMDNasdaqCIK 1819253HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$44.2mRevenue, Q2 FY2026, three months to 2026-06-30$44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 7, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$44.2mRevenue, Q2 FY2026, three months to 2026-06-30$44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure−9.5% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin−7.9%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Revenue: $44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure−30.0 pts on a year earlier
  • Net margin−14.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Revenue: $44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure−21.4 pts on a year earlier
  • Diluted EPS−$0.23Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figureSign changed from a year earlier
  • Free cash flow−$3.7mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340364. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001193125-26-340364. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$44.2mOperating margin −7.9%
Diluted EPS−$0.23, Q2 FY2026
Free cash flow−$3.7m, Q2 FY2026
biote Corp., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m51.4Revenue, Q3 FY2024, three months to 2024-09-30$51.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Report this figure49.8Revenue, Q4 FY2024, three months to 2024-12-31$49.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Report this figure49.0Revenue, Q1 FY2025, three months to 2025-03-31$49.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure48.9Revenue, Q2 FY2025, three months to 2025-06-30$48.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure48.0Revenue, Q3 FY2025, three months to 2025-09-30$48.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Report this figure46.4Revenue, Q4 FY2025, three months to 2025-12-31$46.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Report this figure44.9Revenue, Q1 FY2026, three months to 2026-03-31$44.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure44.2Revenue, Q2 FY2026, three months to 2026-06-30$44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%23.7%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Revenue: $51.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Report this figure5.6%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Revenue: $49.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Report this figure19.8%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $9.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Revenue: $49.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure22.0%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Revenue: $48.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure17.2%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Revenue: $48.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Report this figure14.7%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Revenue: $46.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Report this figure7.0%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Revenue: $44.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure(7.9%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Revenue: $44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure
Net margin%20.8%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $10.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Revenue: $51.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Report this figure7.4%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $3.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Revenue: $49.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Report this figure28.0%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $13.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Revenue: $49.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure6.5%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Revenue: $48.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure17.1%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Revenue: $48.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Report this figure4.2%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Revenue: $46.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Report this figure5.1%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Revenue: $44.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure(14.8%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Revenue: $44.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure
Diluted EPS$ per share0.33Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Report this figurenot reported (Diluted EPS not reported)0.37Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure0.10Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure0.22Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272294.Report this figurenot reported (Diluted EPS not reported)0.06Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure(0.23)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-340364.Report this figure
Free cash flow$m14.0Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272294. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272294. Derived: 9-month figure less the 6-month figure.Report this figure10.7Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $12.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Report this figure4.8Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Capital expenditure: $1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure5.3Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340364. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001193125-26-340364. Derived: 6-month figure less the 3-month figure.Report this figure13.6Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272294. Derived: 9-month figure less the 6-month figure.Capital expenditure: $499.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001193125-25-272294. Derived: 9-month figure less the 6-month figure.Report this figure6.5Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-13, accession 0001193125-26-106099. Derived: 12-month figure less the 9-month figure.Report this figure3.5Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Capital expenditure: $362.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-216780.Report this figure(3.7)Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-340364. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001193125-26-340364. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$192.2mOperating margin 18.5%
Diluted EPS$0.74, FY2025
Free cash flow$30.2m, FY2025
biote Corp., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m139Revenue, FY2021, twelve months to 2021-12-31$139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-29, accession 0000950170-23-010664.Report this figure165Revenue, FY2022, twelve months to 2022-12-31$165.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-15, accession 0000950170-24-032101.Report this figure185Revenue, FY2023, twelve months to 2023-12-31$185.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-14, accession 0000950170-25-039394.Report this figure197Revenue, FY2024, twelve months to 2024-12-31$197.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure192Revenue, FY2025, twelve months to 2025-12-31$192.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%24.8%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $34.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-29, accession 0000950170-23-010664.Revenue: $139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-29, accession 0000950170-23-010664.Report this figure(36.8%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$60.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-15, accession 0000950170-24-032101.Revenue: $165.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-15, accession 0000950170-24-032101.Report this figure15.5%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $28.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-14, accession 0000950170-25-039394.Revenue: $185.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-14, accession 0000950170-25-039394.Report this figure16.0%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $31.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001193125-26-106099.Revenue: $197.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure18.5%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $35.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-13, accession 0001193125-26-106099.Revenue: $192.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure
Net margin%8.0%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $11.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-04-07, accession 0001193125-22-097864.Revenue: $139.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-29, accession 0000950170-23-010664.Report this figure(0.6%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$969.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-15, accession 0000950170-24-032101.Revenue: $165.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-15, accession 0000950170-24-032101.Report this figure1.8%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-14, accession 0000950170-25-039394.Revenue: $185.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-14, accession 0000950170-25-039394.Report this figure1.6%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001193125-26-106099.Revenue: $197.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure14.1%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $27.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-13, accession 0001193125-26-106099.Revenue: $192.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)(0.12)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-15, accession 0000950170-24-032101.Report this figure0.13Diluted EPS, FY2023, twelve months to 2023-12-31$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-14, accession 0000950170-25-039394.Report this figure0.09Diluted EPS, FY2024, twelve months to 2024-12-31$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure0.74Diluted EPS, FY2025, twelve months to 2025-12-31$0.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure
Free cash flow$m32.3Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $33.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-29, accession 0000950170-23-010664.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-29, accession 0000950170-23-010664.Report this figure(9.5)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-15, accession 0000950170-24-032101.Capital expenditure: $333.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-15, accession 0000950170-24-032101.Report this figure26.5Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $26.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-14, accession 0000950170-25-039394.Capital expenditure: $359.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-14, accession 0000950170-25-039394.Report this figure38.8Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $45.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001193125-26-106099.Capital expenditure: $6.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure30.2Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $35.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-13, accession 0001193125-26-106099.Capital expenditure: $5.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-13, accession 0001193125-26-106099.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding biote Corp.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
325 CAPITAL LLC2026-06-30$8.6m4,548,127Unchanged
Bandera Partners LLC2026-06-30$3.9m2,065,482Unchanged
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$2.1m1,102,753Reduced−11,102
MILLENNIUM MANAGEMENT LLC2026-06-30$824.2k436,088New+436,088
DIMENSIONAL FUND ADVISORS LP2026-06-30$816.1k431,962Reduced−111,532
BlackRock, Inc.2026-06-30$691.6k365,945Reduced−1,373,299
CITADEL ADVISORS LLC2026-06-30$569.5k301,310New+301,310
RICE HALL JAMES & ASSOCIATES, LLC2026-06-30$496.8k262,842Added+12,823
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$492.6k260,488Reduced−355,174
JANE STREET GROUP, LLC2026-06-30$478.8k253,313New+253,313

Recent filings

All 407 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

biote Corp., recent filings
FiledFormWhat it isAccession number
2026-08-0716:30 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-340364
2026-08-0516:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-335200
2026-06-1716:05 ET8-K/A5.02 Departure or appointment of officers or directors0001193125-26-274137
2026-06-0217:17 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-253858
2026-05-1816:30 ET8-K5.07 Shareholder vote results0001193125-26-229013
2026-05-1116:11 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-216780
2026-05-0616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-208965
2026-04-0316:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-142147
2026-04-0216:10 ETDEF 14AProxy statementPeriod 2026-05-120001193125-26-140096
2026-03-1316:04 ET10-KAnnual reportPeriod 2025-12-310001193125-26-106099

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 13, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1819253
Tickers
BTMD
Exchange
Nasdaq
SIC code
2833 Medicinal Chemicals & Botanical Products
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
not reported
Filer category
Accelerated filer<br>Smaller reporting company<br>Emerging growth company
Former names
Haymaker Acquisition Corp. III (to 2022-05-25)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.